1-7 of 7
Hans-Peter Vornlocher
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Targeted Inhibition of the NUP98-NSD1 Fusion Oncogene in AML

Sagarajit Mohanty, MSc, Nidhi Jyotsana, PhD, Amit Sharma, PhD, Basem Othman, Arnold Kloos, PhD, Madhvi Mandhania, MSc, Renate Schottmann, Euan Ramsay, PhD, Hans- Peter Vornlocher, PhD, Arnold Ganser, MD, Felicitas Thol, MD, Michael Heuser, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 2545.
https://doi.org/10.1182/blood-2019-123709
Published: 2019
Journal Articles

Effective Treatment of Human CML By RNAi In Vivo in a Xenotransplantation Mouse Model

Nidhi Jyotsana, PhD, Amit Sharma, PhD MSc, BSc, Anuhar Chaturvedi, PhD MS, BPharm, Colin Walsh, Anitha Thomas, Michaela Scherr, PhD, Matthias Eder, MD, Karin Battmer, Florian Kuchenbauer, MD PhD, Sajti Laszlo, Annette Barchanski, Kerstin Goerlich, Robert Lindner, Fatih Noyan, PhD, Suehs.Kurt Wolfram, Denis Grote-Koska, Korbinian Brand, Hans-Peter Vornlocher, Arnold Ganser, MD, Euan Ramsay, Pieter Cullis, Michael Heuser, MD
Journal: Blood
Blood (2015) 126 (23): 1261.
https://doi.org/10.1182/blood.V126.23.1261.1261
Published: 2015
Journal Articles

Targeting MLL-AF4 with short interfering RNAs inhibits clonogenicity and engraftment of t(4;11)-positive human leukemic cells

Maria Thomas, Andreas Geßner, Hans-Peter Vornlocher, Philipp Hadwiger, Johann Greil, Olaf Heidenreich
Journal: Blood
Blood (2005) 106 (10): 3559–3566.
https://doi.org/10.1182/blood-2005-03-1283
Published: 2005
Journal Articles

Repeated Application of Sequence-Specific SiRNA Molecules Leads to an Effective Downmodulation of All Clinically Relevant bcr-abl Gene Variants.

Lara Wohlbold, Heiko van der Kuip, Alexandra Moehring, Galit Granot, Dr, Moshe Oren, Prof Dr, Hans-Peter Vornlocher, Dr, Walter E. Aulitzky
Journal: Blood
Blood (2004) 104 (11): 4319.
https://doi.org/10.1182/blood.V104.11.4319.4319
Published: 2004
Journal Articles

Suppression of MLL-AF4 by Small Interfering RNAs Inhibits Proliferation and Induces Apoptosis in T(4;11)-Positive SEM Cells.

Johann Greil, Maria Thomas, Christian Huenefeld, Hans-Peter Vornlocher, Philipp Hadwiger, Olaf Heidenreich
Journal: Blood
Blood (2004) 104 (11): 4433.
https://doi.org/10.1182/blood.V104.11.4433.4433
Published: 2004
Journal Articles

Inhibition of bcr-abl gene expression by small interfering RNA sensitizes for imatinib mesylate (STI571)

Brief Report
Lara Wohlbold, Heiko van der Kuip, Cornelius Miething, Hans-Peter Vornlocher, Cornelius Knabbe, Justus Duyster, Walter E. Aulitzky
Journal: Blood
Blood (2003) 102 (6): 2236–2239.
https://doi.org/10.1182/blood-2002-12-3899
Published: 2003
Journal Articles

AML1/MTG8 oncogene suppression by small interfering RNAs supports myeloid differentiation of t(8;21)-positive leukemic cells

Olaf Heidenreich, Jürgen Krauter, Heidemarie Riehle, Philipp Hadwiger, Matthias John, Gerhard Heil, Hans-Peter Vornlocher, Alfred Nordheim
Journal: Blood
Blood (2003) 101 (8): 3157–3163.
https://doi.org/10.1182/blood-2002-05-1589
Published: 2003